Amino Acid Disorders 3
The Amino Acid Disorders 3 session will be discussing NKH, Lysine metab (GA1 and PDE).
Commercial Supporter
This educational activity is supported by an educational grant from Ultragenyx.
Learning Objectives
- Recall how to diagnosis patients with disorders of glycine and lysine metabolism through biochemical or genetic testing.
- Describe the phenotypic heterogeneity of patients with glycine and lysine metabolism disorders.
- Summarize common treatment approaches for patients with glycine and lysine metabolism disorders.
Medical Biochemical Genetics is hosted virtually via Zoom. Zoom details will be provided after registering for the course.
Guest Faculty
Nicholas Ah Mew, MD
Children's National Hospital
Disclosures
Nicholas Ah Mew, MD, speaker for this activity, is a consultant for Satellite Bio, ModernaTherapeutics, Jnana Therapeutics and Ultragenyx and a clinical trial principal investigatorfor Aeglea Biotherapeutics, Hemoshear Therapeutics and Recordati Rare Disease.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Medical
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance